Seok-Joong Kim

Prof. Dr. Seok-Joong Kim


Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
DTDunxian Tan
Dunxian Tan
XZXiaodong Zheng
Xiaodong Zheng
Jin KongJin Kong
Jin Kong
LMLucien C. Manchester
Lucien C. Manchester
RHRuediger Hardeland
Ruediger Hardeland
Russel ReiterRussel Reiter
Russel Reiter
Melatonin and melatonin isomers exist and/or coexist in living organisms including yeasts, bacteria and plants. The levels of melatonin isomers are significantly higher than that of melatonin in some plants and in several fermented products such as in wine and bread. Currently, there are no reports documenting the presence of melatonin isomers in vertebrates. From an evolutionary point of view, it is unlikely that melatonin isomers do not exist in vertebrates. On the other hand, large quantities of the microbial flora exist in the gut of the vertebrates. These microorganisms frequently exchange materials with the host. Melatonin isomers, which are produced by these organisms inevitably enter the host’s system. The origins of melatonin and its isomers can be traced back to photosynthetic bacteria and other primitive unicellular organisms. Since some of these bacteria are believed to be the precursors of mitochondria and chloroplasts these cellular organelles may be the primary sites of melatonin production in animals or in plants, respectively. Phylogenic analysis based on its rate-limiting synthetic enzyme, serotonin N-acetyltransferase (SNAT), indicates its multiple origins during evolution. Therefore, it is likely that melatonin and its isomer are also present in the domain of archaea, which perhaps require these molecules to protect them against hostile environments including extremely high or low temperature. Evidence indicates that the initial and primary function of melatonin and its isomers was to serve as the first-line of defence against oxidative stress and all other functions were acquired during evolution either by the process of adoption or by the extension of its antioxidative capacity.

29 November 2017 in BMC Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
DJDaun Jeon
Daun Jeon
SKSeok-Joong Kim
Seok-Joong Kim
HKHong Seok Kim
Hong Seok Kim
Atherosclerosis is a chronic vascular inflammatory disease. Since even low-level endotoxemia constitutes a powerful and independent risk factor for the development of atherosclerosis, it is important to find therapies directed against the vascular effects of endotoxin to prevent atherosclerosis. Taraxacum officinale (TO) is used for medicinal purposes because of its choleretic, diuretic, antioxidative, anti-inflammatory, and anti-carcinogenic properties, but its anti-inflammatory effect on endothelial cells has not been established. We evaluated the anti-inflammatory activity of TO filtered methanol extracts in LPS-stimulated human umbilical vein endothelial cells (HUVECs) by monocyte adhesion and western blot assays. HUVECs were pretreated with 100 μg/ml TO for 1 h and then incubated with 1 μg/ml LPS for 24 h. The mRNA and protein expression levels of the targets (pro-inflammatory cytokines and adhesion molecules) were analyzed by real-time PCR and western blot assays. We also preformed HPLC analysis to identify the components of the TO methanol extract. The TO filtered methanol extracts dramatically inhibited LPS-induced endothelial cell–monocyte interactions by reducing vascular cell adhesion molecule-1 and monocyte chemoattractant protein-1, and pro-inflammatory cytokine expression. TO suppressed the LPS-induced nuclear translocation of NF-κB, whereas it did not affect MAPK activation. Our findings demonstrated that methanol extracts of TO could attenuate LPS-induced endothelial cell activation by inhibiting the NF-κB pathway. These results indicate the potential clinical benefits and applications of TO for the prevention of vascular inflammation and atherosclerosis.

Verified
Journal Article
Open access
PDF file
SKSe Gie Kim
Se Gie Kim
SKSeok-Joong Kim
Seok-Joong Kim
VDVan-Thanh Duong
Van-Thanh Duong
YCYuhan Cho
Yuhan Cho
BPBogeun Park
Bogeun Park
JHJong Chan Hong
Jong Chan Hong
Triple-negative breast cancer (TNBC) presents a significant challenge in oncology due to its aggressive nature and limited targeted therapeutic options. This study explores the potential of autocrine motility factor (AMF) and an AMF-derived peptide as novel treatments for TNBC. AMF, primarily secreted by neoplastic cells, plays a crucial role in cancer cell motility, metastasis, and proliferation. The research demonstrates that AMF and its derived peptide inhibit TNBC cell proliferation by modulating cellular migration, redox homeostasis, apoptotic pathways, and drug efflux mechanisms. Dose-dependent antiproliferative effects were observed across three TNBC cell lines, with higher concentrations impairing cellular migration. Mechanistic studies revealed decreased glucose-6-phosphate dehydrogenase expression and elevated reactive oxygen species production, suggesting redox imbalance as a primary mediator of apoptosis. Combination studies with conventional therapeutics showed near-complete eradication of resistant TNBC cells. The observed reduction in p53 levels and increased intranuclear doxorubicin accumulation highlight the AMF/AMF peptide’s potential as multidrug resistance modulators. This study underscores the promise of using AMF/AMF peptide as a novel therapeutic approach for TNBC, addressing current treatment limitations and warranting further investigation.

1 January 2000
Verified
Journal Article
Closed access
SKSeok-Joong Kim
Seok-Joong Kim
Russel ReiterRussel Reiter
Russel Reiter
WQWenbo Qi
Wenbo Qi
DDDun-Xian Tan Dx
Dun-Xian Tan Dx
JCJavier Cabrera
Javier Cabrera

30 October 2025 in Food Science and Preservation
Verified
Journal Article
Open access
PDF file
SMSunmi Moon
Sunmi Moon
YKYangji Kim
Yangji Kim
SKSeok-Joong Kim
Seok-Joong Kim
Aquafaba has attracted attention as a promising substitute for egg whites due to its excellent foaming properties; however, it still has limitations in fully replicating the texture and functional characteristics of egg whites, particularly in products such as meringue cookies. In this study, the effect of xanthan gum addition on improving the quality of meringue cookies made with aquafaba as an egg white substitute was investigated. Xanthan gum demonstrated superior enhancement of aquafaba’s foaming stability and firmness compared to guar gum and gum arabic. When added at concentrations ranging from 0.1 to 1.5% (w/w), xanthan gum reduced bubble size and increased both the viscosity and firmness of the aquafaba meringue batter, thereby improving foam stability. Analysis of the final meringue cookies showed that the sample containing 0.5% xanthan gum most closely resembled egg white-based cookies in terms of appearance and crust texture. Additionally, it exhibited a denser internal pore structure and greater volume, indicating an overall enhancement in product quality. These results suggest that the addition of 0.5% xanthan gum is optimal for producing aquafaba-based meringue cookies with structural and textural properties comparable to those made with egg whites.

1 December 2016 in Korean Journal of Food Preservation
Verified
Journal Article
Open access
PDF file
SKSeok-Joong Kim
Seok-Joong Kim
한국식품저장유통학회지(Korean Journal of Food Preservation)